Abiopharma

Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

BioLineRx to Report Second Quarter 2025 Results on August 14, 2025

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy

Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update

New Form 6-K - Haleon plc Filed: 2025-08-07 AccNo: 0001654954-25-009157 Size: 39 KB

New Form 10-Q - IMMUNIC, INC. Filed: 2025-08-07 AccNo: 0001280776-25-000012 Size: 12 MB

New Form 8-K - Warby Parker Inc. Filed: 2025-08-07 AccNo: 0001504776-25-000024 Size: 456 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Warby Parker - Warby Parker Announces Second Quarter 2025 Results

Warby Parker Announces Second Quarter 2025 Results

Lilly reports second-quarter 2025 financial results and raises guidance